08048035968
Hepatitis MYHEP ALL Tablets trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

MYHEP ALL Tablet is a fixed-dose combination of two direct-acting antiviral medicines: Sofosbuvir 400 mg + Velpatasvir 100 mg. It belongs to the class of medicines used against Hepatitis C virus infection. The product is available as a 28-tablet pack and is a prescription medicine.

It is designed to inhibit important viral proteins involved in HCV replication, helping reduce the amount of virus in the body and supporting viral clearance when used as prescribed.

2. Product Information

  • Brand Name: MYHEP ALL Tablets
  • Active Ingredients: Sofosbuvir 400 mg + Velpatasvir 100 mg
  • Dosage Form: Film-coated tablet
  • Route of Administration: Oral
  • Typical Pack Size: 28 tablets
  • Therapeutic Class: Hepatitis C antivirals
  • Manufacturer/Marketer: Mylan Pharmaceuticals / Mylan Laboratories
  • Origin: India
  • Prescription Status: Prescription medicine

3. Uses of MYHEP ALL Tablets

MYHEP ALL is primarily used for the treatment of chronic Hepatitis C virus (HCV) infection. Sofosbuvir and velpatasvir provide activity against multiple HCV genotypes, and treatment selection depends on the patient's individual clinical condition.

The medicine may be prescribed for eligible patients with different stages of chronic HCV infection, including some patients with liver cirrhosis, depending on medical assessment and treatment guidelines.

4. Benefits of MYHEP ALL Tablets

Potential benefits when appropriately prescribed include:

  • Helps suppress HCV replication.
  • Combines two antiviral mechanisms in one tablet.
  • Provides broad activity across major HCV genotypes.
  • Convenient once-daily oral administration.
  • Can help achieve sustained virologic response (SVR), meaning HCV RNA remains undetectable after successful treatment.
  • May help reduce the long-term consequences associated with chronic HCV infection when treatment successfully clears the virus.

Important: Treatment success depends on the HCV genotype, liver condition, previous treatment, other medicines, adherence, and the treatment regimen selected by the physician.

5. Side Effects of MYHEP ALL Tablets

Not everyone experiences side effects. Possible adverse effects can include:

  • Headache
  • Fatigue or tiredness
  • Nausea
  • Diarrhea
  • Difficulty sleeping
  • Irritability
  • Skin rash
  • Vomiting

Some adverse effects may be more noticeable when MYHEP ALL is used with other medicines such as ribavirin.

Seek urgent medical attention for serious symptoms such as severe allergic reactions, significant breathing difficulty, fainting, or symptoms suggestive of liver problems.

6. Common Side Effects

The commonly reported side effects include:

  1. Headache
  2. Fatigue
  3. Nausea
  4. Diarrhea
  5. Insomnia or difficulty sleeping
  6. Vomiting
  7. Skin rash

Most mild side effects may improve during treatment, but persistent or troublesome symptoms should be discussed with a healthcare professional.

7. How to Use MYHEP ALL Tablets

Take MYHEP ALL exactly according to your doctor's prescription.

  • The commonly recommended regimen is one tablet once daily.
  • It may generally be taken with or without food.
  • Try to take it at approximately the same time each day.
  • Swallow the tablet whole; do not crush or chew it.
  • Complete the prescribed treatment duration even if you feel better.
  • Do not change the dose or stop treatment without consulting your doctor.
  • If you miss a dose, follow your doctor's or pharmacist's instructions rather than taking an extra dose on your own.

Treatment duration can vary according to the patient's medical condition and treatment regimen, so the physician should determine the appropriate duration.

8. How MYHEP ALL Tablets Work

MYHEP ALL combines two direct-acting antiviral medicines:

Sofosbuvir: inhibits the HCV NS5B RNA-dependent RNA polymerase, an enzyme required for viral RNA replication.

Velpatasvir: inhibits the HCV NS5A protein, which plays an important role in viral replication and assembly.

By targeting two different stages of the HCV life cycle, the combination helps prevent the virus from multiplying and can lead to clearance of HCV when the prescribed treatment is successful.

9. Safety Advice for MYHEP ALL Tablets

  • Use this medicine only under appropriate medical supervision.
  • Tell your doctor if you have liver disease, kidney disease, or are receiving dialysis.
  • Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and supplements you take.
  • Particular attention is needed with medicines that affect stomach acidity, certain HIV medicines, and amiodarone because clinically important drug interactions can occur.
  • Patients with previous or current Hepatitis B infection should inform their doctor because Hepatitis B reactivation can occur during treatment with direct-acting antivirals.
  • Discuss pregnancy and breastfeeding with your doctor before starting treatment.
  • Avoid self-medication and do not share this prescription medicine with another person.
  • Store the medicine according to the manufacturer's instructions; a commonly listed storage condition is below 30°C.
  • Alcohol use should be discussed with your doctor, particularly if there is existing liver disease.

10. Frequently Asked Questions (FAQs)

Q1. What is MYHEP ALL Tablet used for?
MYHEP ALL is used to treat chronic Hepatitis C virus (HCV) infection.

Q2. What does MYHEP ALL contain?
Each tablet contains Sofosbuvir 400 mg and Velpatasvir 100 mg.

Q3. How often is MYHEP ALL usually taken?
The commonly recommended dosage is one tablet once daily, but the exact treatment regimen should be determined by a healthcare professional.

Q4. Can MYHEP ALL be taken with food?
Yes. It can generally be taken with or without food.

Q5. Can I stop MYHEP ALL when I feel better?
No. Do not stop treatment without your doctor's advice because completing the prescribed antiviral regimen is important.

Q6. Can MYHEP ALL be used during pregnancy?
Pregnancy considerations depend on the complete treatment regimen, particularly if ribavirin is included. Discuss pregnancy or plans for pregnancy with your doctor before treatment.

Q7. Can MYHEP ALL interact with other medicines?
Yes. Important interactions are possible, including with certain medicines used for heart conditions, HIV treatment, and medicines affecting gastric acidity. Always provide your doctor with a complete medication list.

Q8. Is MYHEP ALL a prescription medicine?
Yes. It is classified as a prescription medicine and should be used under medical supervision.

Q9. What should I do if I miss a dose?
Follow the missed-dose instructions provided by your healthcare professional or product information. Do not take an extra dose without professional advice.

Q10. Is MYHEP ALL suitable for everyone with Hepatitis C?
Not necessarily. Treatment selection depends on factors such as HCV genotype, liver status, previous treatment, other medicines, and other medical conditions.

11. Substitutes for MYHEP ALL Tablets

MYHEP ALL contains Sofosbuvir 400 mg + Velpatasvir 100 mg. Other products containing the same active ingredients may be considered therapeutic alternatives, but the brand, manufacturer, regulatory approval, availability, and formulation can differ by country.

Examples of products containing the same combination include Sofosbuvir/Velpatasvir 400 mg/100 mg tablets from different manufacturers. A physician or pharmacist should confirm that a substitute is appropriate before changing products.

12. SEO & B2B Keywords

  • MYHEP ALL Tablets exporter from India
  • MYHEP ALL Tablets supplier from India
  • MYHEP ALL Tablets pharmaceutical exporter
  • MYHEP ALL 400mg 100mg Tablets supplier
  • Sofosbuvir 400mg Velpatasvir 100mg exporter
  • Sofosbuvir Velpatasvir Tablets exporter India
  • MYHEP ALL medicine exporter from Nagpur
  • MYHEP ALL Tablets wholesale supplier India
  • MYHEP ALL Tablets international supplier
  • MYHEP ALL Tablets pharmaceutical supplier
  • MYHEP ALL Tablets export to USA
  • MYHEP ALL Tablets export to UK
  • MYHEP ALL Tablets export to Australia
  • MYHEP ALL Tablets export to Singapore
  • MYHEP ALL Tablets export to Canada
  • MYHEP ALL Tablets export to South Korea
  • MYHEP ALL Tablets export to UAE
  • Hepatitis C medicine exporter India
  • Hepatitis C antiviral medicine supplier
  • Sofosbuvir Velpatasvir medicine exporter
  • Generic Hepatitis C medicine supplier India
  • Pharmaceutical medicine exporter Nagpur India
  • Prescription medicine exporter India
  • Indian pharmaceutical exporter to international markets
  • MYHEP ALL 28 Tablets supplier
  • Sofosbuvir Velpatasvir 400mg/100mg supplier
  • Hepatitis C treatment medicine supplier India
  • MYHEP ALL pharmaceutical wholesale supplier
  • MYHEP ALL international medicine supplier
  • MYHEP ALL tablets B2B pharmaceutical supplier
Aug 21st, 2026 1:03 PM

Keywords